share_log

4: Statement of changes in beneficial ownership of securities-Officer Shah Vinay

4: Statement of changes in beneficial ownership of securities-Officer Shah Vinay

4:持股變動聲明-高管 Shah Vinay
美股SEC公告 ·  11/18 22:05

牛牛AI助理已提取核心訊息

Vinay Shah, the Chief Financial Officer of Adial Pharmaceuticals, Inc. (ADIL), was involved in a transaction on November 16, 2024. The specific details of the transaction, including the action type, status, number of shares, nature of shares, transaction price, and post-transaction holdings, were not disclosed in the announcement. As a key executive of the company, any trading activity by Shah is closely monitored by investors and could potentially influence the market's perception of the stock.
Vinay Shah, the Chief Financial Officer of Adial Pharmaceuticals, Inc. (ADIL), was involved in a transaction on November 16, 2024. The specific details of the transaction, including the action type, status, number of shares, nature of shares, transaction price, and post-transaction holdings, were not disclosed in the announcement. As a key executive of the company, any trading activity by Shah is closely monitored by investors and could potentially influence the market's perception of the stock.
Vinay Shah,致富金融(臨時代碼)的首席財務官,於2024年11月16日參與了一項交易。公告中未披露交易的具體細節,包括行動類型、狀態、股份數量、股份性質、交易價格和交易後持股情況。作爲公司的關鍵高管,Shah的任何交易活動都受到投資者的密切關注,並可能影響市場對該股票的看法。
Vinay Shah,致富金融(臨時代碼)的首席財務官,於2024年11月16日參與了一項交易。公告中未披露交易的具體細節,包括行動類型、狀態、股份數量、股份性質、交易價格和交易後持股情況。作爲公司的關鍵高管,Shah的任何交易活動都受到投資者的密切關注,並可能影響市場對該股票的看法。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。